Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

New method shows that tau forms small aggregates as part of the body's normal physiology

New method shows that tau forms small aggregates as part of the body's normal physiology

6 May 2021
Pioneering neural recordings lay the groundwork for personalized Parkinson's treatments

Pioneering neural recordings lay the groundwork for personalized Parkinson's treatments

4 May 2021
Four-part small-molecule cocktail can prevent cellular stress

Four-part small-molecule cocktail can prevent cellular stress

4 May 2021
The vulnerable homebound are left behind on vaccination

The vulnerable homebound are left behind on vaccination

30 Apr 2021
International task force questions the applicability, relevance of current Parkinson's disease subtyping

International task force questions the applicability, relevance of current Parkinson's disease subtyping

30 Apr 2021
Single protein could be a new target for delaying onset of aging symptoms in the brain

Single protein could be a new target for delaying onset of aging symptoms in the brain

29 Apr 2021
New model may explain the perplexing asymmetrical motor symptoms in Parkinson's disease

New model may explain the perplexing asymmetrical motor symptoms in Parkinson's disease

28 Apr 2021
Leveraging vibrations and ultrasound waves to diagnose, treat brain ailments

Leveraging vibrations and ultrasound waves to diagnose, treat brain ailments

28 Apr 2021
Researchers survey patients to find out which Parkinson's symptoms troubled the most

Researchers survey patients to find out which Parkinson's symptoms troubled the most

27 Apr 2021
Altered neural functioning in Parkinson's patients changes the way art is perceived and valued

Altered neural functioning in Parkinson's patients changes the way art is perceived and valued

23 Apr 2021
Listening to music can help older adults sleep better, finds study

Listening to music can help older adults sleep better, finds study

21 Apr 2021
Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

19 Apr 2021
SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

19 Apr 2021
Study provides new insights into how signal molecules are transported in the axons

Study provides new insights into how signal molecules are transported in the axons

17 Apr 2021
Researchers visualize fast brain signals from outside the skull

Researchers visualize fast brain signals from outside the skull

16 Apr 2021
Researchers invent new technique to measure the speed of fibril growth

Researchers invent new technique to measure the speed of fibril growth

16 Apr 2021
Personality trait neuroticism associated with higher risk of Parkinson's disease

Personality trait neuroticism associated with higher risk of Parkinson's disease

15 Apr 2021
Non-invasive neuromodulation approaches can prevent invasive surgery in Parkinson's patients

Non-invasive neuromodulation approaches can prevent invasive surgery in Parkinson's patients

13 Apr 2021
New grants could help protect the environment and create new therapy for Parkinson's

New grants could help protect the environment and create new therapy for Parkinson's

12 Apr 2021
New digital platform to aid young Aussies living with incurable movement disorder

New digital platform to aid young Aussies living with incurable movement disorder

9 Apr 2021

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback